Updated Jul 16, 2026
Marshak Richard has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $16K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 561 | $3.87 | $2K |
| 2026-05-19 | TLSI | TriSalus Life Sciences, Inc. | S — Open-market sale | 543 | $2.67 | $1K |
| 2026-03-20 | TLSI | TriSalus Life Sciences, Inc. | S — Open-market sale | 419 | $4.12 | $2K |
| 2026-03-20 | TLSI | TriSalus Life Sciences, Inc. | S — Open-market sale | 1.6K | $4.09 | $6K |
| 2026-03-20 | TLSI | TriSalus Life Sciences, Inc. | S — Open-market sale | 1.4K | $4.13 | $6K |
| 2024-11-15 | TLSI | TriSalus Life Sciences, Inc. | A — Grant or award | 6.9K | $0.00 |
Marshak Richard is a corporate insider — currently tracked as Chief Commercial Officer of TriSalus Life Sciences, Inc. (TLSI). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($16K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Marshak Richard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.